Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications
Open Access
- 1 September 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in The AAPS Journal
- Vol. 7 (3), E503-E512
- https://doi.org/10.1208/aapsj070351
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Renal Failure with the Use of Zoledronic AcidThe New England Journal of Medicine, 2003
- A population pharmacokinetic model for zoledronic acid (ZOMETA) in patients with bone metastasesClinical Pharmacology & Therapeutics, 2003
- Intravenous Nesiritide vs Nitroglycerin for Treatment of Decompensated Congestive Heart FailureJAMA, 2002
- Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia.Journal of Pharmacokinetics and Pharmacodynamics, 2001
- Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart FailureThe New England Journal of Medicine, 2000
- Impact of Population Pharmacokinetic- Pharmacodynamic Analyses on the Drug Development ProcessClinical Pharmacokinetics, 2000
- An Evaluation of the Integration of Pharmacokinetic and Pharmacodynamic Principles in Clinical Drug DevelopmentClinical Pharmacokinetics, 1997
- Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of TransplantationBlood, 1997
- Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantationCancer Chemotherapy and Pharmacology, 1989